The monkeypox outbreak was declared a public health emergency in August 2022 due to the rapidly rising cases across the nation.
“Monkeypox is a viral infection that is very contagious. This virus is currently spreading and while rare, it is something to be aware of in the pediatric and adolescent population. Children with eczema and/or other immunocompromised conditions may be at a higher risk of having severe monkeypox infection, making prevention essential.
Monkeypox can mimic other much more common infections including: molluscum contagiosum, hand, foot and mouth disease (HFMD) and chickenpox. Flu-like symptoms followed by a rash that can present as blisters, pimples or pox may appear around the mouth, private areas and on the palms of hands and soles of the feet. It can be spread through body fluids, wounds, contaminated objects, and respiratory droplets.
Please exhibit caution if your child has come into physical contact with an individual who has been diagnosed. If you have concerns that your child may have been exposed, or if they are exhibiting symptoms please seek care from your healthcare provider.”
These recent developments demonstrate the importance of staying up-to-date on emerging issues and how they can impact particular patient populations.
To stay abreast of the latest developments, treatments, and therapies in pediatric dermatology, consider attending LiVDerm’s upcoming Masters of Pediatric Dermatology Symposium in February 2023. Participants will have the opportunity to take a deep dive into some of the most common pediatric skin concerns, with presentations from LiVDerm’s expert faculty.
This is a unique opportunity to expand your knowledge and improve your awareness of the various issues and concerns faced by your pediatric patients.